If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)

ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.



Obituary: Michael H. Auerbach

by Linda Wang
March 28, 2020 | A version of this story appeared in Volume 98, Issue 12


This is a photo of Michael Auerbach.
Credit: Courtesy of David Auerbach
Michael Auerbach

Michael H. Auerbach, 76, died on Feb. 11 in Suffern, New York.

“Michael did analytical R&D at Monsanto’s polymer and petrochemical division in Springfield, Massachusetts, starting in 1969. He moved to Pfizer’s industrial specialty chemical division in 1976 as manager of applications. He was promoted to senior associate director of regulatory affairs when Pfizer transitioned away from specialty chemicals and formed its food science group. Among his accomplishments, he assisted in the development of a high-pyruvate xanthan gum for enhanced oil recovery and polycarboxylate antiscalants for water desalination and geothermal power; was responsible for a clinical trial of the high-intensity sweetener alitame in Australia; established the generally-recognized-as-safe status of the reduced-calorie fat replacer salatrim; assisted in the development of EverFresh, an antienzymatic browning agent for shrimp; and established worldwide acceptance of the dietary fiber status of the low-calorie bulking agent polydextrose.”—David Auerbach, son

Most recent title: Food regulatory affairs scientist, DuPont

Education: BS, chemistry, Massachusetts Institute of Technology, 1964; PhD, analytical chemistry, Cornell University, 1970

Survivors: Wife, Cheryl, daughters, Karen and Sara; son, David; four grandchildren

To recognize your late loved one or colleague, submit obituary information at


This article has been sent to the following recipient:

Chemistry matters. Join us to get the news you need.